Super thought-provoking first day at the immuno-oncology breakthroughs conference, located at the stunning la pedrera. Loaded up on tapas ready for day 2! #eacrImmunoOncology

excited to share results of first #clinicaltrial of oncolytic viral + immunotherapy for #GBM published in @naturemedicine nature.com/articles/s4159… University of Toronto Neurosurgery UHN Research Krembil Brain Institute Princess Margaret Cancer Centre Research

Final version of my thesis submitted, roll on graduation!🎓

Very exciting to see our TME subtypes being applied to assess the outcome of oncolytic virus therapy in GBM. Interesting to see TME-Med appears to be associated with improved response to DNX-2401 + anti-PD1 treatment

Today's The Irish Times features a magazine dedicated to the pioneering work of the Beaumont RCSI Beaumont RCSI Cancer Centre.   Read how the Centre is leading the fight against cancer with patient-partnered care informed by research.   Pick up a copy or read online: bit.ly/Cancercentre

Great to see our three ⁦Physiology RCSI⁩ PhD and MD students who graduated today from ⁦RCSI⁩ with their supervisors as well as Heiko and Ina who support them during COVID and beyond! ⁦Annette Byrne⁩ ⁦Shona Pfeiffer⁩

Late breaking at #ASCO23: Mutations in isocitrate dehydrogenase 1 or 2 are common in low-grade glioma. The IDH inhibitor vorasidenib improved progression-free survival as compared with placebo. Full results of the INDIGO trial: nej.md/3N8N5dU

“Seeing these patients do well on the trial has been really gratifying," said Patrick Wen, director of the center for neuro-oncology Dana-Farber. Read more in The Wall Street Journal about this treatment breakthrough for an intractable brain cancer, presented at #ASCO23: wsj.com/articles/treat…

Great 1st Plenary meeting for the GLIORESOLVE network today. Welcoming our new students, catching up with some familiar faces and meeting some people in person for the first time 🙏 Looking forward to the next 3.5 years! Annette Byrne @MSCActions Horizon Europe 🇪🇺 Horizon Europe Ireland

Delighted to have the opportunity to present at the GLIORESOLVE welcome meeting. Exciting times ahead!

Excellent talk from @sautesfridm explaining the role of TLS and B cells in immunotherapy response at the #CICON conference in Milan. Exciting to see our recent TLS findings in GBM included!

Great opportunity to discuss our data at the #CICON23 conference. Establishing a clinically relevant GBM model is critical to understand treatment response + ultimately translate novel TME targeting agents to the clinic

Honoured to receive the RAMI award for best oncology paper in 2022!A massive thank you to Annette Byrne and all the incredible collaborations throughout my #GLIOTRAIN PhD GLIORESOLVE for making this possible. You can read the paper here: annalsofoncology.org/article/S0923-…

RAMI Research Awards, 25th Sept 2023, short-listed entries and winners. Congrats to all rami.ie/event/rami-res…

If you're interested in how our immune system and immune-directed interventions interact with cancer, you'd be hard pressed to find a better, up-to-date review than this one cell.com/immunity/fullt… Immunity TurleyLab . .

And another potential oncolytic virus response win for glioblastoma! Clinical trial links oncolytic immunoactivation to survival in glioblastoma nature.com/articles/s4158…